Cedar Mountain Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Cedar Mountain Advisors's AMGN Position: Q2 2026 in Review
Cedar Mountain Advisors held its Amgen (AMGN) position steady in Q2 2026 at 34 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #448.
Cedar Mountain Advisors first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $19K in Q1 2022. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cedar Mountain Advisors held 34 shares of Amgen worth $12.3K as of Q2 2026.
- Cedar Mountain Advisors left its Amgen share count unchanged in Q2 2026.
- Amgen made up ﹤0.01% of Cedar Mountain Advisors's portfolio in Q2 2026, its #448 holding.
- Cedar Mountain Advisors first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- Cedar Mountain Advisors's Amgen position peaked at $19K in Q1 2022.
- 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cedar Mountain Advisors's 13F filing for Q2 2026, filed 2 Jul 2026.